DSHEA third-party literature enforcement by FDA to focus on "blatant misuse".
This article was originally published in The Tan Sheet
Executive Summary
DSHEA THIRD-PARTY LITERATURE PROVISION ENFORCEMENT TO FOCUS ON "BLATANT MISUSE" of books, publications, articles or abstracts used in connection with the sale of dietary supplements, according to a "preliminary draft" of an FDA implementation plan for the Dietary Supplement Health & Education Act. The new law says that so-called third-party literature can be sold with supplements if it is not false or misleading, does not promote a particular brand, is displayed with other materials to present a balanced view of the scientific information, and is physically separate from the supplements.